vs

Side-by-side financial comparison of Natera, Inc. (NTRA) and Qnity Electronics, Inc. (Q). Click either name above to swap in a different company.

Qnity Electronics, Inc. is the larger business by last-quarter revenue ($1.3B vs $665.5M, roughly 1.9× Natera, Inc.). Qnity Electronics, Inc. runs the higher net margin — 16.5% vs 7.1%, a 9.4% gap on every dollar of revenue. On growth, Natera, Inc. posted the faster year-over-year revenue change (39.8% vs 11.1%). Qnity Electronics, Inc. produced more free cash flow last quarter ($568.0M vs $37.8M).

Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women’s health, cancer, and organ health. Natera’s proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendment...

NTRA vs Q — Head-to-Head

Bigger by revenue
Q
Q
1.9× larger
Q
$1.3B
$665.5M
NTRA
Growing faster (revenue YoY)
NTRA
NTRA
+28.6% gap
NTRA
39.8%
11.1%
Q
Higher net margin
Q
Q
9.4% more per $
Q
16.5%
7.1%
NTRA
More free cash flow
Q
Q
$530.2M more FCF
Q
$568.0M
$37.8M
NTRA

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
NTRA
NTRA
Q
Q
Revenue
$665.5M
$1.3B
Net Profit
$47.3M
$211.0M
Gross Margin
45.1%
Operating Margin
-3.4%
21.3%
Net Margin
7.1%
16.5%
Revenue YoY
39.8%
11.1%
Net Profit YoY
187.9%
6.0%
EPS (diluted)
$0.36
$1.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NTRA
NTRA
Q
Q
Q4 25
$665.5M
Q3 25
$592.2M
$1.3B
Q2 25
$546.6M
Q1 25
$501.8M
Q4 24
$476.1M
Q3 24
$439.8M
$1.1B
Q2 24
$413.4M
Q1 24
$367.7M
Net Profit
NTRA
NTRA
Q
Q
Q4 25
$47.3M
Q3 25
$-87.5M
$211.0M
Q2 25
$-100.9M
Q1 25
$-66.9M
Q4 24
$-53.8M
Q3 24
$-31.6M
$199.0M
Q2 24
$-37.5M
Q1 24
$-67.6M
Gross Margin
NTRA
NTRA
Q
Q
Q4 25
Q3 25
45.1%
Q2 25
Q1 25
Q4 24
Q3 24
47.0%
Q2 24
Q1 24
Operating Margin
NTRA
NTRA
Q
Q
Q4 25
-3.4%
Q3 25
-16.5%
21.3%
Q2 25
-20.2%
Q1 25
-15.8%
Q4 24
-13.6%
Q3 24
-8.9%
21.8%
Q2 24
-10.6%
Q1 24
-20.2%
Net Margin
NTRA
NTRA
Q
Q
Q4 25
7.1%
Q3 25
-14.8%
16.5%
Q2 25
-18.5%
Q1 25
-13.3%
Q4 24
-11.3%
Q3 24
-7.2%
17.3%
Q2 24
-9.1%
Q1 24
-18.4%
EPS (diluted)
NTRA
NTRA
Q
Q
Q4 25
$0.36
Q3 25
$-0.64
$1.01
Q2 25
$-0.74
Q1 25
$-0.50
Q4 24
$-0.41
Q3 24
$-0.26
$0.95
Q2 24
$-0.30
Q1 24
$-0.56

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NTRA
NTRA
Q
Q
Cash + ST InvestmentsLiquidity on hand
$128.0M
Total DebtLower is stronger
$1.7B
Stockholders' EquityBook value
$1.7B
$9.1B
Total Assets
$2.4B
$12.5B
Debt / EquityLower = less leverage
0.19×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NTRA
NTRA
Q
Q
Q4 25
Q3 25
$1.0M
$128.0M
Q2 25
$16.0M
Q1 25
$17.8M
Q4 24
$22.7M
Q3 24
$29.5M
Q2 24
$90.3M
Q1 24
$69.1M
Total Debt
NTRA
NTRA
Q
Q
Q4 25
Q3 25
$1.7B
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
NTRA
NTRA
Q
Q
Q4 25
$1.7B
Q3 25
$1.3B
$9.1B
Q2 25
$1.2B
Q1 25
$1.2B
Q4 24
$1.2B
Q3 24
$878.5M
$11.1B
Q2 24
$836.5M
Q1 24
$794.1M
Total Assets
NTRA
NTRA
Q
Q
Q4 25
$2.4B
Q3 25
$1.8B
$12.5B
Q2 25
$1.8B
Q1 25
$1.7B
Q4 24
$1.7B
Q3 24
$1.6B
Q2 24
$1.5B
Q1 24
$1.5B
Debt / Equity
NTRA
NTRA
Q
Q
Q4 25
Q3 25
0.19×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NTRA
NTRA
Q
Q
Operating Cash FlowLast quarter
$73.9M
$782.0M
Free Cash FlowOCF − Capex
$37.8M
$568.0M
FCF MarginFCF / Revenue
5.7%
44.5%
Capex IntensityCapex / Revenue
5.4%
16.8%
Cash ConversionOCF / Net Profit
1.56×
3.71×
TTM Free Cash FlowTrailing 4 quarters
$109.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NTRA
NTRA
Q
Q
Q4 25
$73.9M
Q3 25
$59.4M
$782.0M
Q2 25
$37.6M
Q1 25
$44.5M
Q4 24
$52.9M
Q3 24
$51.8M
Q2 24
$4.0M
Q1 24
$27.0M
Free Cash Flow
NTRA
NTRA
Q
Q
Q4 25
$37.8M
Q3 25
$37.0M
$568.0M
Q2 25
$11.7M
Q1 25
$22.6M
Q4 24
$34.8M
Q3 24
$35.5M
Q2 24
$-7.7M
Q1 24
$6.7M
FCF Margin
NTRA
NTRA
Q
Q
Q4 25
5.7%
Q3 25
6.2%
44.5%
Q2 25
2.1%
Q1 25
4.5%
Q4 24
7.3%
Q3 24
8.1%
Q2 24
-1.9%
Q1 24
1.8%
Capex Intensity
NTRA
NTRA
Q
Q
Q4 25
5.4%
Q3 25
3.8%
16.8%
Q2 25
4.7%
Q1 25
4.3%
Q4 24
3.8%
Q3 24
3.7%
Q2 24
2.8%
Q1 24
5.5%
Cash Conversion
NTRA
NTRA
Q
Q
Q4 25
1.56×
Q3 25
3.71×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NTRA
NTRA

Segment breakdown not available.

Q
Q

Semiconductor Technologies$693.0M54%
Interconnect Solutions$583.0M46%

Related Comparisons